South Korea Immuno-oncology Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2028

1.     Report Overview

1.1.  Report Description

1.2.  Research Methods

1.3.  Research Approaches

2.     Executive Summary

3.     Market Overview

3.1.  Introduction

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

3.3.  PEST-Analysis

3.4.  Porter's Diamond Model for South Korea Immuno-oncology Market

3.5.  IGR-Growth Matrix Analysis

3.6.  Competitive Landscape in South Korea Immuno-oncology Market

4.     South Korea Immuno-oncology Market by Type

4.1.  Immune Cell Therapy

4.2.  Monoclonal Antibodies

4.3.  Checkpoint Inhibitors

4.4.  Cytokines

4.5.  Cancer Vaccines

4.6.  Others

5.     South Korea Immuno-oncology Market by Targets

5.1.  LAG-3

5.2.  Anti-CTLA-4

5.3.  MAGE-A3

5.4.  VEGF

5.5.  HDAC

5.6.  Others

6.     South Korea Immuno-oncology Market by Indication

6.1.  Malignant Tumors

6.2.  Benign Tumors

6.3.  Others

7.     South Korea Immuno-oncology Market by End Users

7.1.  Hospitals

7.2.  Specialty Clinics

7.3.  Others

8.     Company Profiles

8.1.  Company 1

8.2.  Company 2

8.3.  Company 3

8.4.  Company 4

8.5.  Company 5